Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antimicrobial treatment of pulmonary colonization and infection by pseudomonas aeruginosa in cystic fibrosis patients.

× No keyword cloud information.

5 in total

1. Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs.

Authors: J S Elborn; R J Prescott; B H Stack; M C Goodchild; J Bates; C Pantin; N Ali; D J Shale; M Crane
Journal: Thorax Date: 2000-05 Impact factor: 9.139

2. P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients.

Authors: U S Sajjan; L T Tran; N Sole; C Rovaldi; A Akiyama; P M Friden; J F Forstner; D M Rothstein
Journal: Antimicrob Agents Chemother Date: 2001-12 Impact factor: 5.191

Review 3. Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.

Authors: Susan M Cheer; John Waugh; Stuart Noble
Journal: Drugs Date: 2003 Impact factor: 9.546

4. Epidemiological analysis of sequential Pseudomonas aeruginosa isolates from chronic bronchiectasis patients without cystic fibrosis.

Authors: I Pujana; L Gallego; G Martín; F López; J Canduela; R Cisterna
Journal: J Clin Microbiol Date: 1999-06 Impact factor: 5.948

5. Tobramycin administered by the TOBI(®) Podhaler(®) for persons with cystic fibrosis: a review.

Authors: Donald R Vandevanter; David E Geller
Journal: Med Devices (Auckl) Date: 2011-09-20

5 in total